Heartburn Medication Recalled

Dr Reddy’s Laboratories Inc is recalling 8976 bottles of over-the-counter omeprazole delayed-release capsules after a customer reported a staple mixed in with capsules in a bottle. The recall appeared in the October 27, 2021, US Food and Drug Administration (FDA) Enforcement Report. 

The recall affects omeprazole delayed-release capsules, 20 mg (equivalent to 20.6 mg omeprazole magnesium), 14-count bottles (NDC 70000-0232-1), with the code BT001594C. The bottles were distributed by Cardinal Health, Dublin, OH, throughout the United States. 

Dr Reddy’s Laboratories voluntarily initiated the recall October 5, 2021. On October 22, 2021, the FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists. 

Delayed-release omeprazole 20 mg is an over-the-counter acid reducer.